Mental health differences between frequent cannabis users with and without dependence and the general population

Addiction

Volumn 108, Issue 8, 2013, Pages 1459-1469

  Van der Pol, Peggy ^a   Liebregts, Nienke ^b   De Graaf, Ron ^a   Ten Have, Margreet ^a   Korf, Dirk J ^b   Van den Brink, Wim ^b   Van Laar, Margriet ^a  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dependence; Frequent cannabis use; General population; Mental disorders

Indexed keywords

ADOLESCENT; ADULT; CANNABIS SMOKING; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MOTIVATION; NETHERLANDS; PREVALENCE; PSYCHOLOGY; SOCIOECONOMICS; YOUNG ADULT; ARTICLE; CANNABIS ADDICTION; DEPENDENT PERSONALITY DISORDER; FREQUENT CANNABIS USE; MENTAL DISEASE; POPULATION; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MENTAL DISORDERS; MOTIVATION; NETHERLANDS; PREVALENCE; SOCIOECONOMIC FACTORS; YOUNG ADULT;

DEPENDENCE; FREQUENT CANNABIS USE; GENERAL POPULATION; MENTAL DISORDERS;

EID: 84880313888     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12196     Document Type: Article

References (58)

1. Hall W. The adverse health effects of cannabis use: what are they, and what are their implications for policy? Int J Drug Policy 2009; 20: 458-466.
2. Fergusson D. M., Boden J. M. Cannabis use and later life outcomes. Addiction 2008; 103: 969-976.
3. Cheung J. T., Mann R. E., Ialomiteanu A., Stoduto G., Chan V., Ala-Leppilampi K. etal. Anxiety and mood disorders and cannabis use. Am J Drug Alcohol Abuse 2010; 36: 118-122.
4. Mathews R. R., Hall W. D., Gartner C. E. Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. Med J Aust 2011; 195: S12-S15.
5. Swift W., Hall W., Teesson M. Cannabis use and dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. Addiction 2001; 96: 737-748.
6. Degenhardt L., Coffey C., Romaniuk H., Swift W., Carlin J. B., Hall W. D. etal. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 2013; 108: 124-133.
7. Grant B. F., Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse 1998; 10: 255-264.
8. Coffey C., Carlin J. B., Degenhardt L., Lynskey M., Sanci L., Patton G. C. Cannabis dependence in young adults: an Australian population study. Addiction 2002; 97: 187-194.
9. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual Report: The State of the Drugs Problem in Europe. Lisbon: EMCDDA; 2009, p. 38-47.
10. Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493-1504.
11. Crippa J. A., Zuardi A. W., Martin-Santos R., Bhattacharyya S., Atakan Z., McGuire P. etal. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 2009; 24: 515-523.
12. Stinson F. S., Ruan W. J., Pickering R., Grant B. F. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 2006; 36: 1447-1460.
13. Bovasso G. B. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158: 2033-2037.
14. Agosti V., Nunes E., Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 2002; 28: 643-652.
15. Chen C. Y., Wagner F. A., Anthony J. C. Marijuana use and the risk of major depressive episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 199-206.
16. Conway K. P., Compton W., Stinson F. S., Grant B. F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67: 247-257.
17. Zvolensky M. J., Bernstein A., Sachs-Ericsson N., Schmidt N. B., Buckner J. D., Bonn-Miller M. O. Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. J Psychiatr Res 2006; 40: 477-486.
18. Kouri E., Pope H. G., Jr, Yurgelun-Todd D., Gruber S. Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry 1995; 38: 475-481.
19. Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M. etal. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-328.
20. Lee S. S., Humphreys K. L., Flory K., Liu R., Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011; 31: 328-341.
21. Pingault J. B., Cote S. M., Galera C., Genolini C., Falissard B., Vitaro F. etal. Childhood trajectories of inattention, hyperactivity and oppositional behaviors and prediction of substance abuse/dependence: a 15-year longitudinal population-based study. Mol Psychiatry 2012. doi: 10.1038/mp.2012.87.
22. Looby A., Earleywine M. Negative consequences associated with dependence in daily cannabis users. Subst Abuse Treat Prev Policy 2007; 2: 3.
23. Degenhardt L., Hall W., Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 219-227.
24. Palmer R. H., Young S. E., Hopfer C. J., Corley R. P., Stallings M. C., Crowley T. J. etal. Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 2009; 102: 78-87.
25. Wittchen H. U., Frohlich C., Behrendt S., Gunther A., Rehm J., Zimmermann P. etal. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007; 88 (Suppl 1): S60-S70.
26. Lopez-Quintero C., Cobos J. P., Hasin D. S., Okuda M., Wang S., Grant B. F. etal. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2011; 115: 120-130.
27. Reigstad B., Jorgensen K., Wichstrom L. Diagnosed and self-reported childhood abuse in national and regional samples of child and adolescent psychiatric patients: prevalences and correlates. Nord J Psychiatry 2006; 60: 58-66.
28. Hayatbakhsh M. R., Najman J. M., Jamrozik K., Mamun A. A., Alati R. Do parents' marital circumstances predict young adults' DSM-IV cannabis use disorders? A prospective study. Addiction 2006; 101: 1778-1786.
29. Oshri A., Rogosch F. A., Burnette M. L., Cicchetti D. Developmental pathways to adolescent cannabis abuse and dependence: child maltreatment, emerging personality, and internalizing versus externalizing psychopathology. Psychol Addict Behav 2011; 25: 634-644.
30. Noack R., Höfler M., Gründler R., Becker A., Schulz R., Paul K. Consumption patterns as covariates of DSM-IV cannabis dependence. Sucht 2009; 55: 137-147.
31. Temple E. C., Brown R. F., Hine D. W. The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction 2011; 106: 238-244.
32. Walden N., Earleywine M. How high: quantity as a predictor of cannabis-related problems. Harm Reduct J 2008; 5: 20.
33. Noack R., Hofler M., Lueken U. Cannabis use patterns and their association with DSM-IV cannabis dependence and gender. Eur Addict Res 2011; 17: 321-328.
34. Bonn-Miller M. O., Zvolensky M. J. An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict 2009; 18: 409-416.
35. Chabrol H., Duconge E., Casas C., Roura C., Carey K. B. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 2005; 30: 829-840.
36. Johnson K., Mullin J. L., Marshall E. C., Bonn-Miller M. O., Zvolensky M. Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. Am J Addict 2010; 19: 277-282.
37. Milich R., Lynam D., Zimmerman R., Logan T. K., Martin C., Leukefeld C. etal. Differences in young adult psychopathology among drug abstainers, experimenters, and frequent users. J Subst Abuse 2000; 11: 69-88.
38. Van der Pol P., Liebregts N., De Graaf R., Korf D. J., Van den Brink W., van Laar M. The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. Int J Methods Psychiatr Res 2011; 20: 169-181.
39. Wouters M., Korf D. Access to licensed cannabis supply and the separation of markets policy in the Netherlands. J Drug Issues 2009; 39: 627-651.
40. De Graaf R., Ten Have M., Van Dorsselaer S. The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods. Int J Methods Psychiatr Res 2010; 19: 125-141.
41. Von Sydow K., Lieb R., Pfister H., Hofler M., Wittchen H. U. What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend 2002; 68: 49-64.
42. De Graaf R., Bijl R. V., Ten Have M., Beekman A. T., Vollebergh W. A. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord 2004; 82: 461-467.
43. Hovens J. G., Wiersma J. E., Giltay E. J., van Oppen P., Spinhoven P., Penninx B. W. etal. Childhood life events and childhood trauma in adult patients with depressive, anxiety and comorbid disorders vs. controls. Acta Psychiatr Scand 2010; 122: 66-74.
44. Janssen I., Krabbendam L., Bak M., Hanssen M., Vollebergh W., de Graaf R. etal. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 2004; 109: 38-45.
45. Konings M., Stefanis N., Kuepper R., de Graaf R., Ten H. M., van Os J. etal. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychol Med 2012; 42: 149-159.
46. Simons J. S., Gaher R. M., Correia C. J., Hansen C. L., Christopher M. S. An affective-motivational model of marijuana and alcohol problems among college students. Psychol Addict Behav 2005; 19: 326-334.
47. Gutierres R. G. Use of the term 'relative risk ratio'. Available at: http://www.stata.com/statalist/archive/2005-04/msg00678.html Archived by WebCite® at http://www.webcitation.org/6BG3PLTaK Statacorp. 2005 (accessed 8 October 2012).
48. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr 1997; 167: 17-36.
49. Zaldivar Basurto F., Garcia Montes J. M., Flores Cubos P., Sanchez Santed F., Lopez Rios F., Molina Moreno A. Validity of the self-report on drug use by university students: correspondence between self-reported use and use detected in urine. Psicothema 2009; 21: 213-219.
50. Wilens T. E., Martelon M., Joshi G., Bateman C., Fried R., Petty C. etal. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011; 50: 543-553.
51. Elkins I. J., McGue M., Iacono W. G. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64: 1145-1152.
52. Kessler R. C., Price R. H. Primary prevention of secondary disorders: a proposal and agenda. Am J Community Psychol 1993; 21: 607-633.
53. Clark H. W., Power A. K., Le Fauve C. E., Lopez E. I. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat 2008; 34: 3-13.
54. Merikangas K. R., Li J. J., Stipelman B., Yu K., Fucito L., Swendsen J. etal. The familial aggregation of cannabis use disorders. Addiction 2009; 104: 622-629.
55. Verweij K. J., Zietsch B. P., Lynskey M. T., Medland S. E., Neale M. C., Martin N. G. etal. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 2010; 105: 417-430.
56. Van Laar M., Cruts G., Van Ooyen-Houben M., Croes E., Van Gageldonk A., Meijer R. etal. The Netherlands Drug Situation 2011: Report to the EMCDDA by the Reitox National Focal Point. Utrecht: Trimbos Institute, Netherlands Institute of Mental Health and Addiction; 2012.
57. Hall W., Swift W. The THC content of cannabis in Australia: evidence and implications. Aust NZ J Public Health 2000; 24: 503-508.
58. Fox C. L., Towe S. L., Stephens R. S., Walker D. D., Roffman R. A. Motives for cannabis use in high-risk adolescent users. Psychol Addict Behav 2011; 25: 492-500.